USH2A and retinal degeneration: Potential therapeutic strategies can be divided in two main types: USH2A-targeted therapy, which manipulate levels of USH2A; and USH2A-independent therapy, which aims to prevent retinal degeneration through targeting common disease pathways such as cell death or oxidative stress (Fig. 4).